Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth-quarter of 2025 and provided 2026 financial guidance.

Received $350 Million in upfront cash at closing; Up to $425 Million in total proceeds inclusive of near-term earnout payments Approximately $550 Million in cash & cash equivalents on balance sheet at ...

Origami Therapeutics, a biotech company developing small molecule protein degraders and conformation correctors to treat ...

Seegnal Inc. (TSXV: SEGN), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced its deepened partnership with Tel Aviv Sourasky ...

Beyond the general buzz, CES 2026 highlighted some specific, exciting areas of AI development. We’re seeing AI move into more ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Doing HIIT workouts can improve your cardiovascular and ...